About Holmusk
Holmusk is transforming neuropsychiatry with the field's largest clinical dataset, unlocking evidence for better decisions and improved outcomes.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
New York, United States
Tracked Since
Sep 29, 2026
Web & Domain Identity
Official Website
holmusk.com
Domain Registered Date
Feb 10, 2015
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Series-B+ announced
fundraisingfox.com
- Capital Raise
Raised $21,500,000 · Series-A
- Milestone
X account created (@holmusk)
336 followers
- Milestone
Website domain registered
holmusk.com
Investors & Backers
Health Catalyst Capital
Northwell Holdings
Novartis Venture Fund
Octave
Optum Ventures
Veradigm
Funding History
Series-B+
· Feb 14, 2026
Undisclosed fundraisingfox.com
Series-A
· May 18, 2020
$21,500,000 Source
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026